This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2019-2024.
Location History:
- Hildesheim/Itzum, DE (2019)
- Hildesheim, DE (2024)
Company Filing History:
Years Active: 2019-2024
Title: Andrea Bethe: Innovator in Glycoconjugate Vaccine Development
Introduction
Andrea Bethe is a notable inventor based in Hildesheim, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of glycoconjugate vaccines. Her innovative work focuses on the production of polysaccharides that can be utilized in vaccine formulations.
Latest Patents
Andrea Bethe holds a patent titled "Means and methods for producing phosphate containing capsular polysaccharides." This invention relates to a host cell that contains a polynucleotide under the control of a heterologous promoter. The polynucleotide encodes a polypeptide capable of synthesizing a polysaccharide consisting of a dimeric repeating unit. The patent also describes a vaccine composition that includes such a host cell, which can be used for producing glycoconjugate vaccines.
Career Highlights
Andrea is affiliated with the Medizinische Hochschule Hannover (MHH), where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of polysaccharides in vaccine technology.
Collaborations
Andrea collaborates with esteemed colleagues, including Timm Fiebig and Christa Litschko, who contribute to her research endeavors. Their combined expertise enhances the potential impact of their work in the field of vaccine development.
Conclusion
Andrea Bethe's innovative contributions to glycoconjugate vaccine development highlight her role as a leading inventor in biotechnology. Her patent and ongoing research efforts are paving the way for advancements in vaccine technology.